Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention

• Published in: Biochemical pharmacology 2023-02, Vol.208, p.115413-115413, Article 115413
• Main Authors: Gribkoff, Valentin K., Winquist, Raymond J.
• Format: Article
• Language: English
• Subjects: Adult; BK channel; Calcium Channels - genetics; Calcium-dependent potassium channel; Channel activator; Channel inhibitor; Channelopathies - genetics; Channelopathies - therapy; Channelopathy; Epilepsy; Epilepsy - drug therapy; Epilepsy - genetics; Epilepsy, Benign Neonatal - genetics; Humans; Infant, Newborn; KCNMA1 channelopathies; KCNQ channel; KCNT1 channelopathies; Mutation; Neonatal; Nerve Tissue Proteins - metabolism; Neuronal; Potassium channel; Potassium Channels, Sodium-Activated - genetics; Seizure; Slack channel; Sodium-dependent potassium channel; Syndrome
• ISSN: 0006-2952; 1873-2968
• DOI: 10.1016/j.bcp.2023.115413

[Display omitted] A number of mutations to members of several CNS potassium (K) channel families have been identified which result in rare forms of neonatal onset epilepsy, or syndromes of which one prominent characteristic is a form of epilepsy. Benign Familial Neonatal Convulsions or Seizures (BFNC or BFNS), also referred to as Self-Limited Familial Neonatal Epilepsy (SeLNE), results from mutations in 2 members of the KV7 family (KCNQ) of K channels; while generally self-resolving by about 15 weeks of age, these mutations significantly increase the probability of generalized seizure disorders in the adult, in some cases they result in more severe developmental syndromes. Epilepsy of Infancy with Migrating Focal Seizures (EIMSF), or Migrating Partial Seizures of Infancy (MMPSI), is a rare severe form of epilepsy linked primarily to gain of function mutations in a member of the sodium-dependent K channel family, KCNT1 or SLACK. Finally, KCNMA1 channelopathies, including Liang-Wang syndrome (LIWAS), are rare combinations of neurological symptoms including seizure, movement abnormalities, delayed development and intellectual disabilities, with Liang-Wang syndrome an extremely serious polymalformative syndrome with a number of neurological sequelae including epilepsy. These are caused by mutations in the pore-forming subunit of the large-conductance calcium-activated K channel (BK channel) KCNMA1. The identification of these rare but significant channelopathies has resulted in a resurgence of interest in their treatment by direct pharmacological or genetic modulation. We will briefly review the genetics, biophysics and pharmacology of these K channels, their linkage with the 3 syndromes described above, and efforts to more effectively target these syndromes.